Sentynl secures US-first approval for rare Menkes disease
The US biopharma company can now offer a new treatment…
The US biopharma company can now offer a new treatment option for eligible paediatric patients with the genetic disease.
List view / Grid view
The US biopharma company can now offer a new treatment…
The US biopharma company can now offer a new treatment option for eligible paediatric patients with the genetic disease.
She will become the fifth leader at the Center, following…
She will become the fifth leader at the Center, following the surprise retirement decision by her soon-to-be predecessor Richard Pazdur.